Macrolide- and Telithromycin-resistant Streptococcus pyogenes, Belgium, 1999–20031
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Macrolide- and Telithromycin-resistant Streptococcus pyogenes, Belgium, 1999–20031
  • Published Date:

    Jun 2005

  • Source:
    Emerg Infect Dis. 11(6):939-942.
Filetype[PDF-102.26 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 574.09 KB]
    Personal Author:
    Zheng, Xiaotian; Lee, Stella; Selvarangan, Rangaraj; Qin, Xuan; Tang, Yi-Wei; Stiles, Jeffrey; Hong, Tao; Todd, Kathleen; Ratliff, Amy E.; Crabb, Donna M.; Xiao, Li; Atkinson, T. Prescott; Waites, Ken B.;
    Published Date:
    Aug 2015
    Source:
    Emerg Infect Dis. 21(8):1470-1472.
    Description:
    Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe. Few data on MRMP are available in the United States. Using genotypic and phenotypic methods, we detected high-level MRMP in 13.2% of 9...
    File Type:
    Filetype[PDF - 574.09 KB]
  2. Filetype[PDF - 202.35 KB]
    Personal Author:
    Bassetti, M.; Manno, G.; Collidà, A.; Ferrando, A.; Gatti, G.; Ugolotti, E.; Cruciani, M.; Bassetti, D.;
    Published Date:
    2000 Mar-Apr
    Source:
    Emerg Infect Dis. 6(2):180-183.
    Description:
    In a prospective study of acute pharyngitis in Italian children, 69 (38.3%) of 180 isolates of Streptococcus pyogenes were resistant to macrolides. S. pyogenes was eradicated in 12 (63.1%) of 19 patients with erythromycin-resistant S. pyogenes treate...
    File Type:
    Filetype[PDF - 202.35 KB]
  3. Filetype[PDF - 186.87 KB]
    Personal Author:
    Robinson, Katherine A.; Rothrock, Gretchen; Phan, Quyen; Sayler, Brenda; Stefonek, Karen; Van Beneden, Chris; Levine, Orin S.;
    Corporate Authors:
    for the Active Bacterial Core Surveillance/Emerging Infections Program Network
    Published Date:
    Apr 2003
    Source:
    Emerg Infect Dis. 9(4):443-447
    Description:
    From January 1997 to April 1999, we determined attack rates for cases of invasive group A streptococcal (GAS) disease in household contacts of index patients using data from Active Bacterial Core Surveillance sites. Of 680 eligible index-patient hous...
    File Type:
    Filetype[PDF - 186.87 KB]
  4. Filetype[PDF - 136.96 KB]
    Personal Author:
    Manning, Susan E.; Lee, Elsie; Bambino, Maribeth; Ackelsberg, Joel; Weiss, Don; Sathyakumar, Chiminyan; Kornblum, John; Barbot, Oxiris; Johnson, Dwight; Kaplan, Edward L.; Layton, Marcelle;
    Published Date:
    Jan 2005
    Source:
    Emerg Infect Dis. 11(1):146-149.
    Description:
    After being notified that 2 high school football teammates from New York City were hospitalized with confirmed or suspected invasive group A streptococcal infections, we conducted an investigation of possible spread among other team members. This inv...
    File Type:
    Filetype[PDF - 136.96 KB]
  5. Filetype[PDF - 312.48 KB]
    Personal Author:
    Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi;
    Published Date:
    Sep 2012
    Source:
    Emerg Infect Dis. 18(9):1515-1518.
    Description:
    In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical thresho...
    File Type:
    Filetype[PDF - 312.48 KB]